ID: iSRL-26-03-R-Allergen
The contributors whose contribution match the standards required will co-author the final report and will be published under iSRL in Zenodo. Co-authorships are reserved for anyone who contributes substantially to this report, namely
- Contributing by submitting at least 1 subpart.
- Peer review and verify citations of the submission made by another contributor for at least 2 sub parts.
Any other contribution will be stated in the acknowledgments. You can pick one sub part to start with and once you complete it, you can move to the next. If you want to pick a sub part but it's already been claimed by someone else, you can offer to co-author the analysis or peer review it.
Related outputs for methodology reference:
- Report — Indian Supreme Court: Hierarchical Classification, doi:10.5281/zenodo.18651646
- Report — Regulatory Delta: FSSAI 2011 vs 2020, doi:10.5281/zenodo.18719394
What this report needs to answer
Allergen declaration in India is governed by specific provisions in the FSSAI Labelling Regulations. The rules exist on paper. How they work in practice — and how India's approach compares to jurisdictions where declaration is more developed — is not well documented in a form that is useful for the IFID classification system.
This report addresses that gap. It is divided into sub-parts so contributors can work on sections independently. The final output is a single report.
Sub-part A: What Indian law currently requires
ID: iSRL-26-03-R-Allergen.SP01
Primary sources to work from:
- FSSAI Food Safety and Standards (Labelling and Display) Regulations, 2020 — Regulation 5(14) specifically, and Schedule VII if present
- FSSAI Food Safety and Standards (Food Products Standards and Food Additives) Regulations, 2011, for any additive-specific allergen provisions
- Any FSSAI orders or notifications issued after 2020 that amend allergen declaration requirements
Questions to answer:
- Which substances are listed as mandatory allergen declarations under current FSSAI rules?
- What triggers the declaration — is there a quantity threshold, a "may contain" provision, or is declaration required regardless of quantity?
- What is the prescribed format: where on the label, in what font size, in what language?
- What does the 2020 regulation require that the 2011 version did not? Cite both documents specifically.
- What does the Delhi High Court ruling in Ram Gaua Raksha Dal v. Union of India (W.P.(C) 12055/2021) establish about source declaration independent of quantity? This ruling is relevant to allergen declaration beyond the scheduled list.
Do not cite news articles or summaries about what FSSAI "plans to do." Cite only what is currently in force.
Sub-part B: How declaration works in practice
ID: iSRL-26-03-R-Allergen.SP02
This sub-part requires evidence — not speculation. If no published data exists on a question, say so explicitly.
Questions to answer:
- What does available evidence show about the rate of allergen declaration on Indian packaged food labels?
- What are the documented enforcement mechanisms? Who enforces, and what does published record of enforcement action show?
- What does the ingredient variant corpus reveal about allergen-relevant ingredients appearing under names that are not obviously allergen-flagged? For example: "besan" as a groundnut-free chickpea flour versus undeclared groundnut cross-contamination risk, or "maida" as a gluten source not explicitly labelled as wheat-derived.
Distinguish clearly between what the regulation requires and what the dataset evidence shows. Do not characterise any gap as intentional non-compliance without evidence of intent.
Sub-part C: How other jurisdictions handle allergen declaration
ID: iSRL-26-03-R-Allergen.SP03
Jurisdictions to cover: EU (Regulation (EU) No 1169/2011), United States (FASTER Act 2021, amending FALCPA 2004), Australia/New Zealand (FSANZ Standard 1.2.3), and at least one other Asian jurisdiction (Japan or South Korea — check which has more complete published standards).
For each jurisdiction, answer:
- Which substances are mandated for declaration?
- Is there a quantity threshold or is declaration quantity-independent?
- Is "may contain" (precautionary allergen labelling) regulated or voluntary?
- What is the prescribed label format?
Primary sources required: cite the actual regulation or standard for each jurisdiction, not a comparison article. Comparison articles can be used to identify which regulation to look up.
Sub-part D: Why the differences exist and what constraints apply in India
ID: iSRL-26-03-R-Allergen.SP04
This sub-part is analysis, not just description. It must distinguish between three types of constraint:
- Regulatory capacity constraints — what FSSAI currently has the infrastructure to enforce
- Industry implementation constraints — what the food manufacturing sector, particularly small and medium manufacturers, can practically declare given current labelling and testing infrastructure
- Data infrastructure constraints — what metadata do we need about an ingredient to tag it as an allergen
For each constraint, describe what the evidence shows. Do not characterise any constraint as an excuse or a failure — describe it as a condition that affects implementation.
Sub-part E: Worldwide allergen burden — which substances affect the most people
ID: iSRL-26-03-R-Allergen.SP05
What this sub-part needs:
- Published epidemiological data on the most common food allergies by affected population, globally and with specific attention to South and Southeast Asian populations where data exists
- Whether the FSSAI mandatory declaration list corresponds to the substances with the highest population burden in India specifically, or whether it follows international lists that may not reflect Indian dietary patterns (e.g., shellfish allergy prevalence differs significantly across populations)
Primary sources required: peer-reviewed epidemiological papers cited by DOI. WHO or FAO reports where relevant. Do not cite allergy awareness organisation websites as primary sources.
Questions to answer:
- Which food substances show the highest allergy prevalence globally by affected population, according to published epidemiological data? Cite the specific studies and their reported figures.
- Which substances appear in India-specific or South Asian epidemiological literature as significant allergens? If published data is sparse or absent for India specifically, state that explicitly — it is a valid finding.
- Does the FSSAI mandatory declaration list correspond to the substances with the highest documented population burden in India, or does it follow international lists (Codex, EU, FASTER Act) that were developed primarily from Western population data?
- Where the FSSAI list and the epidemiological burden diverge — substances with high prevalence not on the list, or substances on the list with limited documented Indian prevalence — document the divergence without characterising it as a regulatory failure. Describe it as a gap between the evidentiary basis of the list and the available population data.
- Are there substances significant in Indian dietary patterns (for example, sesame, mustard, or specific legumes) that appear in epidemiological literature as allergens but are absent from the FSSAI mandatory list? If so, cite the epidemiological source and note the absence from the list factually.
Output format
Single report following IFID writing standards (see STANDARDS.md). Each sub-part becomes a section. The report should be submittable as a standalone document and should be readable by someone who knows food regulation but has not read the IFID corpus.
If any sub-part reveals that the primary sources do not exist, are inaccessible, or are insufficient to answer a question, that finding should be stated explicitly in the relevant section — it is a valid research output.
ID: iSRL-26-03-R-Allergen
The contributors whose contribution match the standards required will co-author the final report and will be published under iSRL in Zenodo. Co-authorships are reserved for anyone who contributes substantially to this report, namely
Any other contribution will be stated in the acknowledgments. You can pick one sub part to start with and once you complete it, you can move to the next. If you want to pick a sub part but it's already been claimed by someone else, you can offer to co-author the analysis or peer review it.
Related outputs for methodology reference:
What this report needs to answer
Allergen declaration in India is governed by specific provisions in the FSSAI Labelling Regulations. The rules exist on paper. How they work in practice — and how India's approach compares to jurisdictions where declaration is more developed — is not well documented in a form that is useful for the IFID classification system.
This report addresses that gap. It is divided into sub-parts so contributors can work on sections independently. The final output is a single report.
Sub-part A: What Indian law currently requires
ID: iSRL-26-03-R-Allergen.SP01
Primary sources to work from:
Questions to answer:
Do not cite news articles or summaries about what FSSAI "plans to do." Cite only what is currently in force.
Sub-part B: How declaration works in practice
ID: iSRL-26-03-R-Allergen.SP02
This sub-part requires evidence — not speculation. If no published data exists on a question, say so explicitly.
Questions to answer:
Distinguish clearly between what the regulation requires and what the dataset evidence shows. Do not characterise any gap as intentional non-compliance without evidence of intent.
Sub-part C: How other jurisdictions handle allergen declaration
ID: iSRL-26-03-R-Allergen.SP03
Jurisdictions to cover: EU (Regulation (EU) No 1169/2011), United States (FASTER Act 2021, amending FALCPA 2004), Australia/New Zealand (FSANZ Standard 1.2.3), and at least one other Asian jurisdiction (Japan or South Korea — check which has more complete published standards).
For each jurisdiction, answer:
Primary sources required: cite the actual regulation or standard for each jurisdiction, not a comparison article. Comparison articles can be used to identify which regulation to look up.
Sub-part D: Why the differences exist and what constraints apply in India
ID: iSRL-26-03-R-Allergen.SP04
This sub-part is analysis, not just description. It must distinguish between three types of constraint:
For each constraint, describe what the evidence shows. Do not characterise any constraint as an excuse or a failure — describe it as a condition that affects implementation.
Sub-part E: Worldwide allergen burden — which substances affect the most people
ID: iSRL-26-03-R-Allergen.SP05
What this sub-part needs:
Primary sources required: peer-reviewed epidemiological papers cited by DOI. WHO or FAO reports where relevant. Do not cite allergy awareness organisation websites as primary sources.
Questions to answer:
Output format
Single report following IFID writing standards (see STANDARDS.md). Each sub-part becomes a section. The report should be submittable as a standalone document and should be readable by someone who knows food regulation but has not read the IFID corpus.
If any sub-part reveals that the primary sources do not exist, are inaccessible, or are insufficient to answer a question, that finding should be stated explicitly in the relevant section — it is a valid research output.